Prices are adjusted according to historical splits.
- Today's Low:
- Today's High:
- Open Price:
- 52W Low:
- 52W High:
- Prev. Close:
- Market Cap.:
- $331.11 million
- Book Value:
- Revenue TTM:
- $516.30 million
- Operating Margin TTM:
- Gross Profit TTM:
- $99.05 million
- Profit Margin:
- Return on Assets TTM:
- Return on Equity TTM:
Invitae Corp had its IPO on 2015-02-12 under the ticker symbol NVTA.
The company operates in the Healthcare sector and Diagnostics & Research industry. Invitae Corp has a staff strength of 1,700 employees.
Shares of Invitae Corp opened at $1.25 at the start of the last trading session i.e. 2023-03-31.
The stocks traded within a range of $1.25 - $1.42, and closed at $1.35.
This is a +9.76% increase from the previous day's closing price.
A total volume of 8,846,643 shares were traded at the close of the day’s session.
In the last one week, shares of Invitae Corp have increased by +5.47%.
Invitae Corp's Key Ratios
Invitae Corp has a market cap of $331.11 million, indicating a price to book ratio of 3.3178 and a price to sales ratio of 0.9413.
In the last 12-months Invitae Corp’s revenue was $516.30 million with a gross profit of $99.05 million and an EBITDA of $-578265024. The EBITDA ratio measures Invitae Corp's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Invitae Corp’s operating margin was -138.34% while its return on assets stood at -12.99% with a return of equity of -201.69%.
In Q4, Invitae Corp’s quarterly earnings growth was a positive 0% while revenue growth was a negative 2.9%.
Invitae Corp’s PE and PEG Ratio
- Forward PE
- Trailing PE
Its diluted EPS in the last 12-months stands at $-12.36 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of -0.51. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Invitae Corp’s profitability.
Invitae Corp stock is trading at a EV to sales ratio of 3.2556 and a EV to EBITDA ratio of -0.5506. Its price to sales ratio in the trailing 12-months stood at 0.9413.
Invitae Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $1.95 billion
- Total Liabilities
- $108.09 million
- Operating Cash Flow
- Capital Expenditure
- $4.92 million
- Dividend Payout Ratio
Invitae Corp ended 2023 with $1.95 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $1.95 billion while shareholder equity stood at $101.84 million.
Invitae Corp ended 2023 with $0 in deferred long-term liabilities, $108.09 million in other current liabilities, 25000.00 in common stock, $-4829141000.00 in retained earnings and $0.00 in goodwill. Its cash balance stood at $257.49 million and cash and short-term investments were $547.10 million. The company’s total short-term debt was $19,721,000 while long-term debt stood at $1.59 billion.
Invitae Corp’s total current assets stands at $693.13 million while long-term investments were $0 and short-term investments were $289.61 million. Its net receivables were $96.15 million compared to accounts payable of $13.98 million and inventory worth $30.39 million.
In 2023, Invitae Corp's operating cash flow was $0 while its capital expenditure stood at $4.92 million.
Comparatively, Invitae Corp paid $0 in dividends in 2023.
Other key metrics
- Current Trading Price
- 52-Week High
- 52-Week Low
- Analyst Target Price
Invitae Corp stock is currently trading at $1.35 per share. It touched a 52-week high of $9.11 and a 52-week low of $9.11. Analysts tracking the stock have a 12-month average target price of $2.26.
Its 50-day moving average was $1.91 and 200-day moving average was $2.49 The short ratio stood at 4.87 indicating a short percent outstanding of 0%.
Around 97.7% of the company’s stock are held by insiders while 6861.7% are held by institutions.
Frequently Asked Questions About Invitae Corp
Similar Industry Stocks (Diagnostics & Research)
Invitae Corporation, a medical genetics company, that provides genetic information to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, precision oncology, women’s health, rare diseases, and pharmacogenomics; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.